Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.

Jain A, Rosell R, Dharmashekara C, Shreevatsa B, González-Cao M, Shivakumar A, Kollur SP, Prasad A, Shivamallu C, Prasad MNN

Open source

DOI: 10.1007/s00210-026-05533-0
Published: 2026 Sep
Container: Naunyn-Schmiedeberg's archives of pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05533-0,
  title = {Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.},
  author = {Jain A and Rosell R and Dharmashekara C and Shreevatsa B and González-Cao M and Shivakumar A and Kollur SP and Prasad A and Shivamallu C and Prasad MNN},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's archives of pharmacology},
  doi = {10.1007/s00210-026-05533-0},
  url = {https://doi.org/10.1007/s00210-026-05533-0}
}

RIS

TY  - JOUR
TI  - Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.
AU  - Jain A
AU  - Rosell R
AU  - Dharmashekara C
AU  - Shreevatsa B
AU  - González-Cao M
AU  - Shivakumar A
AU  - Kollur SP
AU  - Prasad A
AU  - Shivamallu C
AU  - Prasad MNN
PY  - 2026
JO  - Naunyn-Schmiedeberg's archives of pharmacology
DO  - 10.1007/s00210-026-05533-0
UR  - https://doi.org/10.1007/s00210-026-05533-0
ER  -

APA

A, J., R, R., C, D., B, S., M, G., A, S., SP, K., A, P., C, S., & MNN, P. (2026). Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05533-0

Source records

pubmed · retrieved 2026-09-26T23:31:23.796Z